CD163 and COVID-19: Likewise, markers of microbial-mediated myeloid inflammation, i.e. sCD14, sCD163 (monocyte inflammation markers), and MPO (myeloperoxidase; neutrophil inflammation marker) are heightened in severe COVID-19 (229).